Sun may end up with a Compromise!
Its been a year since the Israeli Taro refused to be bought by India’s Sun Pharmaceuticals, good news may finally be coming in. It was reported that the Sun’s CEO Dilip Sanghvi and Taro chairman met at the Mediator Ram Caspi’s place.
The presence of officials from Franklin Templeton which holds over 13% stake in Taro sparks the speculation that there is a strong possibility of a price increase in Sun’s offer.
Sun had dragged Taro when it did not honour its share sale agreement.